FONDATION CONTRE LE CANCER
0873.268.432 · rovalta.com · 23/09/2026
FONDATION CONTRE LE CANCER
Overview
What does FONDATION CONTRE LE CANCER do?
FONDATION CONTRE LE CANCER is a Public utility foundation incorporated in 2005. Its registered office is in Schaerbeek. It employs on average 87,1 ETP workers (FTE).
1030 Schaerbeek · BruxellesSee on map
Joint committees (1)
- 330
Trend over 10 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2019 | 2018 | 2017 | 2016 | 2009 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||
| Revenue | 409,7 k € | -21.2% | 519,7 k € | +19.2% | 436 k € | -13.3% | 503 k € | +0.3% | 501,4 k € | +23297% | 2,1 k € | -97.7% | 94,3 k € | +526% | 15,1 k € | -13.6% | 17,4 k € | -95.3% | 374,9 k € |
| EBITDA | 11,9 M € | +17.0% | 10,1 M € | -19.5% | 12,6 M € | -84.5% | 81,3 M € | +3514% | -2,4 M € | -21052% | 11,4 k € | -99.5% | 2,3 M € | -87.3% | 18,2 M € | +130% | 7,9 M € | +9332% | 84,1 k € |
| Operating result | 11 M € | +18.0% | 9,3 M € | -22.2% | 12 M € | -85.2% | 80,7 M € | +2800% | -3 M € | -365% | -642,5 k € | -134% | 1,9 M € | -89.5% | 17,8 M € | +135% | 7,6 M € | +13283% | -57,4 k € |
| Net result | 22,4 M € | +56.9% | 14,3 M € | -25.5% | 19,1 M € | -74.0% | 73,5 M € | +152995% | 48 k € | -97.5% | 1,9 M € | +96.0% | 979,8 k € | -95.6% | 22,5 M € | +146% | 9,1 M € | +225% | 2,8 M € |
| Balance sheet | |||||||||||||||||||
| Equity | 225,1 M € | +11.0% | 202,7 M € | +7.6% | 188,5 M € | +11.3% | 169,3 M € | +76.7% | 95,8 M € | +0.1% | 95,7 M € | +2.0% | 93,8 M € | +1.1% | 92,8 M € | +31.9% | 70,4 M € | +118% | 32,3 M € |
| Total assets | 240 M € | +9.6% | 219 M € | +4.9% | 208,8 M € | +4.2% | 200,5 M € | +0.1% | 200,3 M € | +19.3% | 167,9 M € | +5.3% | 159,4 M € | +10.0% | 145 M € | +16.6% | 124,4 M € | +116% | 57,6 M € |
| Cash | 2,4 M € | -57.5% | 5,6 M € | +11.5% | 5,1 M € | -81.5% | 27,3 M € | -7.0% | 29,4 M € | +52.5% | 19,3 M € | +284% | 5 M € | -33.2% | 7,5 M € | -69.0% | 24,3 M € | +993% | 2,2 M € |
| Debts | 13,1 M € | -10.9% | 14,7 M € | -23.7% | 19,3 M € | -30.2% | 27,6 M € | -71.9% | 98,3 M € | +40.8% | 69,8 M € | +8.5% | 64,3 M € | +25.2% | 51,4 M € | -3.6% | 53,3 M € | +112% | 25,1 M € |
| Other | |||||||||||||||||||
| Workforce | 87,1 ETP | +3.7% | 84,0 ETP | +4.6% | 80,3 ETP | +10.8% | 72,5 ETP | +3.0% | 70,4 ETP | +0.7% | 69,9 ETP | -2.8% | 71,9 ETP | +9.1% | 65,9 ETP | +7.5% | 61,3 ETP | +29.1% | 47,5 ETP |
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2025 · 16 active · 77 ended
Active mandates
Ended mandates
Other companies at this address
| Company | CBE no. |
|---|---|
All.Can Belgium● Active | 0768.284.243 |
| 0788.690.667 | |
| 0424.778.440 | |
| 0474.209.937 | |
| 0867.170.595 | |
| 0423.587.221 | |
Belgian Hematology Society● Active | 0434.918.405 |
Europacolon Belgium● Active | 0808.403.542 |
| 0450.699.513 | |
| 0465.910.695 | |
OEUVRE BELGE DU CANCER● Active | 0457.127.049 |
SMOKEFREE PARTNERSHIP● Active | 0825.567.394 |
SUN CHILD● Active | 0445.623.344 |
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 13/04/2026 | 24/04/2025 | 16/04/2024 | 28/04/2023 | 17/05/2022 | 24/06/2021 |
| General meeting | 26/03/2026 | 01/04/2025 | 26/03/2024 | 28/03/2023 | 29/03/2022 | 25/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
30 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2025 | 26/03/2026 | 13/04/2026 | French | |
| Full model | 31/12/2025 | 26/03/2026 | 13/04/2026 | Dutch | |
| Full model | 31/12/2024 | 01/04/2025 | 24/04/2025 | Dutch | |
| Full model | 31/12/2024 | 01/04/2025 | 24/04/2025 | French | |
| Full model | 31/12/2023 | 26/03/2024 | 16/04/2024 | Dutch | |
| Full model | 31/12/2023 | 26/03/2024 | 16/04/2024 | French | |
| Full model | 31/12/2022 | 28/03/2023 | 28/04/2023 | Dutch | |
| Full model | 31/12/2022 | 28/03/2023 | 28/04/2023 | French | |
| Full model | 31/12/2021 | 29/03/2022 | 17/05/2022 | French | |
| Full model | 31/12/2021 | 29/03/2022 | 17/05/2022 | Dutch | |
| Full model | 31/12/2020 | 25/05/2021 | 24/06/2021 | French | |
| Full model | 31/12/2020 | 25/05/2021 | 24/06/2021 | Dutch | |
| Full modelCorrection | 31/12/2019 | 26/05/2020 | 07/07/2020 | Dutch | |
| Full modelCorrection | 31/12/2019 | 26/05/2020 | 25/06/2020 | French | |
| Full model | 31/12/2019 | 26/05/2020 | 08/06/2020 | French | |
| Full model | 31/12/2019 | 26/05/2020 | 08/06/2020 | Dutch | |
| Full model | 31/12/2018 | 22/05/2019 | 02/07/2019 | French | |
| Full model | 31/12/2018 | 22/05/2019 | 02/07/2019 | Dutch | |
| Full model | 31/12/2017 | 23/05/2018 | 28/06/2018 | French | |
| Full model | 31/12/2016 | 21/06/2017 | 30/06/2017 | French | |
| Full model | 31/12/2015 | 18/05/2016 | 04/07/2016 | French | |
| Full model | 31/12/2014 | 18/03/2015 | 19/10/2015 | French | |
| Full model | 31/12/2013 | 19/03/2014 | 04/11/2014 | French | |
| Full model | 31/12/2012 | 13/03/2013 | 23/07/2013 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 250 M€ and 500 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2025 · 16 active · 77 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
- Mandates06/11/2025ONTSLAGEN - BENOEMINGEN
- Mandates06/11/2025DEMISSIONS, NOMINATIONS
- Mandates30/07/2025ONTSLAGEN - BENOEMINGEN
- Mandates30/07/2025DEMISSIONS, NOMINATIONS
- Mandates05/09/2024ONTSLAGEN - BENOEMINGEN
- Mandates05/09/2024DEMISSIONS, NOMINATIONS
- Mandates12/04/2024ONTSLAGEN - BENOEMINGEN
- Mandates12/04/2024DEMISSIONS, NOMINATIONS
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 26/01/2026reconductionHilde Knops — bestuurder
- 26/01/2026reconductionHilde Knops — notaire
- 2025Annual accounts 202522,4 M €↑
- 24/06/2025nominationNik GRYMONPREZ — bijzonder mandaat
- 24/06/2025nominationLuitgarde KNOCKAERT — bijzonder mandaat
- 24/06/2025nominationVictoria DE RAEDT — bijzonder mandaat
- 24/06/2025nominationNik GRYMONPREZ — mandat spécial
- 24/06/2025nominationLuitgarde KNOCKAERT — mandat spécial
- 24/06/2025nominationVictoria DE RAEDT — mandat spécial
- 01/04/2025reconductionWerner Claeys — commissaris
- 01/04/2025reconductionGroupe Audit Belgium — commissaire
- 2024Annual accounts 202414,3 M €↓
- 15/11/2024reconductionEric Van Cutsem — bestuurder
- 15/11/2024reconductionWilfried De Neve — bestuurder
- 15/11/2024reconductionEric Van Cutsem — administrateur
- 15/11/2024reconductionWilfried De Neve — administrateur
- 01/09/2024nominationBruno Colmant — bestuurder
- 01/09/2024nominationBruno Colmant — administrateur
- 01/07/2024reconductionRobert de Mûelenaere — bestuurder
- 01/07/2024reconductionMartine De Rouck — bestuurder
- 01/07/2024reconductionMarc Hamoir — bestuurder
- 01/07/2024reconductionRobert de Mûelenaere — administrateur
- 01/07/2024reconductionMartine De Rouck — administrateur
- 01/07/2024reconductionMarc Hamoir — administrateur
- 19/03/2024nominationBruno Marie Léon Nicolas Colmant — persoon belast met het dagelijks bestuur
- 01/01/2024nominationJehanne de Walque — bestuurder
- 01/01/2024nominationJehanne de Walque — administrateur
- 2023Annual accounts 202319,1 M €↓
- 15/10/2023nominationBruno Marie Léon Nicolas Colmant — administrateur
- 15/10/2023nominationBruno Marie Léon Nicolas Colmant — bestuurder
- 26/04/2023nominationKarel Vinck — administrateur
- 26/04/2023nominationJan De Moor — administrateur
- 26/04/2023nominationSébastien Deletaille — administrateur
- 26/04/2023nominationInge Neven — administrateur
- 26/04/2023nominationKarel Vinck — bestuurder
- 26/04/2023nominationJan De Moor — bestuurder
- 26/04/2023nominationSébastien Deletaille — bestuurder
- 26/04/2023nominationInge Neven — bestuurder
- 2022Annual accounts 202273,5 M €↑
- 24/05/2022reconductionProfessor Eric Van Cutsem — Voorzitter
- 24/05/2022reconductionProfessor Pierre Coulie — Voorzitter
- 24/05/2022reconductionPierre Coulie — Président de la Fondation
- 24/05/2022reconductionEric Van Cutsem — Président de la Fondation
- 29/03/2022nominationGroupe Audit Belgium — commissaire
- 29/03/2022nominationGROUPE AUDIT BELGIUM — commissaris
- 2022Name changeSTICHTING TEGEN KANKER
- 2022Name changeFondation contre le Cancer
- 2021Annual accounts 202148 k €↓
- 2021Name changeFONDATION CONTRE LE CANCER - STICHTING TEGEN KANKER
- 22/03/2020revocationBenoit Koerperich — dagelijks bestuur en de vertegenwoordiging
- 22/03/2020revocationBenoit Koerperich — gestion journalière et de représentation
- 2019Annual accounts 20191,9 M €↑
- 2018Annual accounts 2018979,8 k €↓
- 2017Annual accounts 201722,5 M €↑
- 2016Annual accounts 20169,1 M €↑
- 2009Annual accounts 20092,8 M €
- 01/04/2005IncorporationPublic utility foundation